110 related articles for article (PubMed ID: 29185849)
21. Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association.
Whaby M; Wallon L; Mazzei M; Khan I; Teng KW; Koide S; O'Bryan JP
J Biol Chem; 2022 Dec; 298(12):102661. PubMed ID: 36334633
[TBL] [Abstract][Full Text] [Related]
22. Allosteric Regulation of Switch-II Domain Controls KRAS Oncogenicity.
Yang MH; Tran TH; Hunt B; Agnor R; Johnson CW; Shui B; Waybright TJ; Nowak JA; Stephen AG; Simanshu DK; Haigis KM
Cancer Res; 2023 Oct; 83(19):3176-3183. PubMed ID: 37556505
[TBL] [Abstract][Full Text] [Related]
23. Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane.
Lakshman B; Messing S; Schmid EM; Clogston JD; Gillette WK; Esposito D; Kessing B; Fletcher DA; Nissley DV; McCormick F; Stephen AG; Jean-Francois FL
J Biol Chem; 2019 Feb; 294(6):2193-2207. PubMed ID: 30559287
[TBL] [Abstract][Full Text] [Related]
24. Defining bone fide effectors of RAS GTPases.
Smith MJ
Bioessays; 2023 Sep; 45(9):e2300088. PubMed ID: 37401638
[TBL] [Abstract][Full Text] [Related]
25. Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V).
Levinson AM; McGee JH; Roberts AG; Creech GS; Wang T; Peterson MT; Hendrickson RC; Verdine GL; Danishefsky SJ
J Am Chem Soc; 2017 Jun; 139(22):7632-7639. PubMed ID: 28448128
[TBL] [Abstract][Full Text] [Related]
26. Insights into the Cross Talk between Effector and Allosteric Lobes of KRAS from Methyl Conformational Dynamics.
Chao FA; Dharmaiah S; Taylor T; Messing S; Gillette W; Esposito D; Nissley DV; McCormick F; Byrd RA; Simanshu DK; Cornilescu G
J Am Chem Soc; 2022 Mar; 144(9):4196-4205. PubMed ID: 35213144
[TBL] [Abstract][Full Text] [Related]
27. Membrane-Driven Dimerization of the Peripheral Membrane Protein KRAS: Implications for Downstream Signaling.
Lee KY
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473778
[TBL] [Abstract][Full Text] [Related]
28. K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins.
Magits W; Steklov M; Jang H; Sewduth RN; Florentin A; Lechat B; Sheryazdanova A; Zhang M; Simicek M; Prag G; Nussinov R; Sablina A
EMBO J; 2024 Jun; ():. PubMed ID: 38858602
[TBL] [Abstract][Full Text] [Related]
29. Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.
Travers T; López CA; Agamasu C; Hettige JJ; Messing S; García AE; Stephen AG; Gnanakaran S
Biophys J; 2020 Aug; 119(3):525-538. PubMed ID: 32649863
[TBL] [Abstract][Full Text] [Related]
30. Uncovering a membrane-distal conformation of KRAS available to recruit RAF to the plasma membrane.
Van QN; López CA; Tonelli M; Taylor T; Niu B; Stanley CB; Bhowmik D; Tran TH; Frank PH; Messing S; Alexander P; Scott D; Ye X; Drew M; Chertov O; Lösche M; Ramanathan A; Gross ML; Hengartner NW; Westler WM; Markley JL; Simanshu DK; Nissley DV; Gillette WK; Esposito D; McCormick F; Gnanakaran S; Heinrich F; Stephen AG
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24258-24268. PubMed ID: 32913056
[TBL] [Abstract][Full Text] [Related]
31. The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding.
Banerjee A; Jang H; Nussinov R; Gaponenko V
Curr Opin Struct Biol; 2016 Feb; 36():10-7. PubMed ID: 26709496
[TBL] [Abstract][Full Text] [Related]
32. Lysines K117 and K147 play conserved roles in Ras activation from Drosophila to mammals.
Singh J; Karunaraj P; Luf M; Pfleger CM
G3 (Bethesda); 2023 Nov; 13(11):. PubMed ID: 37665961
[TBL] [Abstract][Full Text] [Related]
33. Binding of active Ras and its mutants to the Ras binding domain of PI-3-kinase: A quantitative approach to K
Fleming IR; Hannan JP; Swisher GH; Tesdahl CD; Martyr JG; Cordaro NJ; Erbse AH; Falke JJ
Anal Biochem; 2023 Feb; 663():115019. PubMed ID: 36526022
[TBL] [Abstract][Full Text] [Related]
34. KRAS Ubiquitination at Lysine 104 Retains Exchange Factor Regulation by Dynamically Modulating the Conformation of the Interface.
Yin G; Zhang J; Nair V; Truong V; Chaia A; Petela J; Harrison J; Gorfe AA; Campbell SL
iScience; 2020 Sep; 23(9):101448. PubMed ID: 32882514
[TBL] [Abstract][Full Text] [Related]
35. Conserved allosteric perturbation of the GTPase domains by region 1 of Ras hypervariable regions.
Gu X; Zhang Y; Long D
Biophys J; 2024 Apr; 123(7):839-846. PubMed ID: 38419331
[TBL] [Abstract][Full Text] [Related]
36. The Plasma Membrane as a Competitive Inhibitor and Positive Allosteric Modulator of KRas4B Signaling.
Neale C; García AE
Biophys J; 2020 Mar; 118(5):1129-1141. PubMed ID: 32027820
[TBL] [Abstract][Full Text] [Related]
37. Analysis of context-specific KRAS-effector (sub)complexes in Caco-2 cells.
Ternet C; Junk P; Sevrin T; Catozzi S; Wåhlén E; Heldin J; Oliviero G; Wynne K; Kiel C
Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36894174
[TBL] [Abstract][Full Text] [Related]
38. Investigation of GTP-dependent dimerization of G12X K-Ras variants using ultraviolet photodissociation mass spectrometry.
Mehaffey MR; Schardon CL; Novelli ET; Cammarata MB; Webb LJ; Fast W; Brodbelt JS
Chem Sci; 2019 Sep; 10(34):8025-8034. PubMed ID: 31853358
[TBL] [Abstract][Full Text] [Related]
39. Unveiling the Domain-Specific and RAS Isoform-Specific Details of BRAF Regulation.
Trebino T; Markusic B; Nan H; Banerjee S; Wang Z
bioRxiv; 2023 Sep; ():. PubMed ID: 37163002
[TBL] [Abstract][Full Text] [Related]
40. Kinetic and thermodynamic allostery in the Ras protein family.
Manley LJ; Lin MM
Biophys J; 2023 Oct; 122(19):3882-3893. PubMed ID: 37598291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
